Shanghai - Delayed Quote CNY

DA REN TANG (600329.SS)

32.46
+0.64
+(2.01%)
At close: May 23 at 3:00:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Ms. Lei Wang Chairman of the Board -- -- 1971
Mr. Jian Ma Chief Financial Officer -- -- 1978
Mr. Hong Zhou Deputy GM, Chief Engineer & Executive Director -- -- 1970
Mr. Min Guo Executive Director -- -- 1971
Mr. Yu Zhang Chief Manufacturing Officer -- -- 1973
Mr. Mingjie Shang Executive Director -- -- 1969
Ms. Yan Jiao Secretary to the Board of Directors -- -- 1977

DA REN TANG

No. 17 Baidi Road
Nankai District
Tianjin, 300193
China
86 22 2702 0892 https://www.jydrt.com.cn
Sector: 
Healthcare

Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements. In addition, the company is involved in pharmaceutical and drug retail business. Further, it offers Suxiao Jiuxin pills, Qingyan drop pills, Jingwanhong ointment, Angong Niuhuang pills, Qingfei pills, anti-inflammatory pills, Qinggong Shoutao pills, Biqi capsules, Niuhuang Qingxin pills, Tongmai Yangxin pills, and Weichang An pills. Additionally, the company pharmaceutical logistic services. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.

Corporate Governance

DA REN TANG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 29, 2025 at 9:18 AM UTC

DA REN TANG Earnings Date

Recent Events

July 12, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers